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In Brief
By quantitatively analyzing the COX
intermediates accumulated in a MT-CO3
mutant, Vidoni et al. modify the existing
sequential COX assembly model to a
module-based pathway and describe
MR-1S as a vertebrate-specific factor
involved in COX maturation, cooperating
with the highly conserved PET100 and
PET117 chaperones.
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The biogenesis of human cytochrome c oxidase
(COX) is an intricate process in which three mito-
chondrial DNA (mtDNA)-encoded core subunits are
assembled in a coordinated way with at least 11 nu-
cleus-encoded subunits. Many chaperones shared
between yeast and humans are involved in COX
assembly. Here, we have used aMT-CO3mutant cy-
brid cell line to define the composition of assembly
intermediates and identify new human COX assem-
bly factors. Quantitative mass spectrometry analysis
led us to modify the assembly model from a
sequential pathway to a module-based process.
Each module contains one of the three core sub-
units, together with different ancillary components,
including HIGD1A. By the same analysis, we identi-
fied the short isoform of the myofibrillogenesis
regulator 1 (MR-1S) as a new COX assembly factor,
which works with the highly conserved PET100 and
PET117 chaperones to assist COX biogenesis in
higher eukaryotes.INTRODUCTION
Cytochrome c oxidase (COX) or complex IV (cIV) is the multihe-
teromeric terminal oxidase of the mitochondrial respiratory
chain. Of the 14 structural subunits composing mammalian
COX, three (MT-CO1, CO2, and CO3) are encoded in the mito-
chondrial DNA (mtDNA) and translated inside the organelle.
The remaining 11 subunits and all of the other proteins assisting
the assembly process are imported into the organelle from the
cytoplasm. More than 30 different ancillary proteins are required
for the correct assembly of the 11 structural subunits of yeast
COX (Soto et al., 2012). Several orthologs have been found in hu-
mans, mainly because their mutations determine COX defective
mitochondrial disease (Antonicka et al., 2003a, 2003b; BugianiCell Re
This is an open access article under the CC BY-Net al., 2005; Jaksch et al., 2000; Leary et al., 2004; Lim et al.,
2014; Ola´hova´ et al., 2015; Szklarczyk et al., 2013; Valnot
et al., 2000a, 2000b). The current assembly model for human
COX (Nijtmans et al., 1998; Stiburek et al., 2005, 2006) consists
of four steps: early (step 1 [S1]), intermediate (S2), late (S3), and
last (S4). MT-CO1 is deemed as the first COX component to be
inserted in the inner mitochondrial membrane and constitute
the ‘‘seed’’ onto which the other subunits are assembled (S1).
The incorporation of two early subunits, COX4 and COX5A,
with MT-CO1 forms the S2 intermediate. This is followed by
the incorporation of subunits MT-CO2 and then MT-CO3, which
in turn triggers the ‘‘late’’ incorporation of most of the remaining
accessory subunits (S3), with the exception of COX6A, COX6B,
and COX7A or COX7B, which are incorporated last (S4) (Ferna´n-
dez-Vizarra et al., 2009). The mechanisms and players involved
in this process are relatively well established in yeast (Mick
et al., 2011), whereas the process is less clear and possibly
different in mammals (Dennerlein and Rehling, 2015; Soto
et al., 2012). For instance, specific factors present in mammals
but not in yeast are necessary for the incorporation of MT-CO1
(Clemente et al., 2013; Dennerlein et al., 2015; Mick et al.,
2012) and for stabilization and metalation of MT-CO2 (Bourens
et al., 2014; Leary et al., 2009; Pacheu-Grau et al., 2015; Stroud
et al., 2015).
In order to further define the key steps in COX assembly and
identify new players in human COX biogenesis, we took advan-
tage of a nearly homoplasmic frameshift mutation inMT-CO3 (Ti-
ranti et al., 2000), characterized by the accumulation of assembly
intermediates.RESULTS
Analysis of Assembly Intermediates Recapitulates COX
Biogenesis
Fragment length polymorphism (RFLP) analysis on a cybrid
cell line harboring the m.9536_9537insC (p.Gln111Profs*113)
mutation (Tiranti et al., 2000) in MT-CO3 showed that the muta-
tion load was >95% (Figure S1). By western blot (WB) analysis
of dodecyl-maltoside (DDM)-treated mitochondrial fractions,ports 18, 1727–1738, February 14, 2017 ª 2017 Elsevier Inc. 1727
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. COX Assembly Intermediates in Cybrids Carrying a MT-CO3 Mutation
(A) Mitoplasts isolated from WT and MT-CO3 mutant cybrids analyzed by BNGE and WB using a-MT-CO1. Arrows indicate MT-CO1 in mature COX (cIV),
subassembly intermediates (Sub-cIV), COX dimer (cIV2), and the cIII2 + cIV supercomplex.
(B) Bi-directional SILAC-labeled mitoplasts from both cybrid cell lines were isolated, mixed, and subjected to COX immunocapture. Each data point represents a
specific protein. All of the identified COX subunits were located in the bottom left quadrant. A group of proteins known to be involved in COX assembly, in which
MR-1S was found, is also shown in detail in the top right quadrant. The values in the x axis correspond to the log2 heavy-to-light (H/L) ratio of the peptides
detected in experiment 1, where the heavy (H)-labeled MT-CO3mutant and unlabeled (L) WT cells were mixed. The values in the y axis correspond to the inverted
log2 H/L ratio (log2 H/L) of the peptides detected in experiment 2, where the unlabeled (L) MT-CO3 mutant and the labeled (H) WT cells were mixed.
(C) Table showing the log2 H/L and the log2 H/L ratios obtained for the proteins plotted in (B) by the two-way SILAC mass-spectrometry analysis.run through first-dimension (1D) blue native gel electrophoresis
(BNGE), we detected numerous MT-CO1-containing subassem-
bly species (Figure 1A), which were likely to contain chaperones
involved in COX assembly (Dennerlein and Rehling, 2015). In
order to characterize the composition of the subassembly COX
species, we carried out a comparison of COX immunopurified
from mitoplasts of wild-type (WT) and cybrid mutant cell lines
by quantitative mass spectrometry (MS) analysis using stable
isotope-labeled amino acids in cell culture (SILAC). These exper-
iments were performed in duplicate with reciprocal isotopic la-
beling between mutant and WT cell lines and showed that the
COX subunits were clustered in four distinct groups according
to their relative abundance (Figure 1B; Table S1), in nearly com-
plete concordance with the current COX assembly model (Fer-
na´ndez-Vizarra et al., 2009; Fornuskova et al., 2010; Nijtmans
et al., 1998; Stiburek et al., 2006). Interestingly, the first group1728 Cell Reports 18, 1727–1738, February 14, 2017included COX4I1, COX5A, and HIGD1A, a protein previously
proposed to bind MT-CO1 and regulate COX activity in hypoxia
(Hayashi et al., 2015). The next group was composed of proteins
with 3.5-fold reduction in the mutant cell line and included
MT-CO2, COX5B, COX6C, COX7C, COX8A, and, unexpectedly,
MT-CO1. The third group, with more than 5-fold difference
between mutant and WT complexes, included MT-CO3,
COX6A1, COX6B1, and COX7A2. The last group contained
COX7A2L (also termed super-complex assembly factor 1
[SCAFI]) (Lapuente-Brun et al., 2013), NDUFA4 (Balsa et al.,
2012; Pitceathly et al., 2013), and virtually all of the subunit com-
ponents of complex III (Figure 1B; Table S1). These results reflect
the stalling of COX assembly due to the virtual absence of
MT-CO3 in the mutant cell line, which prevents the formation
of cIII2 + cIV supercomplexes and causes the accumulation of
COX assembly intermediates.
Figure 2. SILAC and Complexome Profiling
Isolated mitochondria from MT-CO3 mutant and control cybrids cells treated with SILAC medium in both orientations were pooled, solubilized with DDM, and
separated by BNGE. Gel lanes were cut into 64 slices (number 1 at the top; number 64 at bottom) followed by liquid chromatography (LC) MS analysis.
(A) Complexome heatmap of wild-type (WT, left) andMT-CO3mutant (right) 143B cybrids. Highlighted in red is slice 39, corresponding to fully assembled COX in
WT cells (215 kDa). COX subunits found under that point are considered to be in COX subassemblies (Sub-cIV).
(B) Profiles of selected proteins in the early, intermediate (intermed.), and last groups (see main text for details). The heatmaps and profiles are shown for the light
WT and heavymutant direction; virtually identical results were obtained by the reverse light mutant and heavyWT direction. For each protein, the relative intensity
(to a maximum of 1) of a representative peptide along the 64 slices was plotted with respect to the molecular mass.These assembly intermediates were also analyzed by ‘‘com-
plexome profiling’’ (Heide et al., 2012). Proteins from mutant
and WT cybrid cells were labeled with SILAC, combined and
resolved by 1D-BNGE, and excised in 64 slices (Figures 2A
and 2B). Figure 2A shows the heatmap of WT mitochondria in
comparison with themutatedmitochondria. InWTmitochondria,
COX subunits are focalized in slice 39 (at a molecular size of
215 kDa), whereas they are much more scattered in the MT-
CO3 mutated cells. The profiles for the individual subunits (Fig-
ure 2B) indicate that subunits COX4I1 and COX5A (not shown),
as well as HIGD1A, are distributed in the bottom part of the gel
(from 30 kDa upward), thus representing early subcomplexes.
In mutant mitochondria, these subunits are predominantly found
in assembly intermediates rather than in (residual) fully assem-
bled COX. The ‘‘intermediate’’ group of subunits was detected
from higher positions along the gel (from 120 kDa upward), andagain, in the mutant cell line, they were predominantly found in
subassemblies rather than in residual fully assembled COX.
Interestingly, the intermediate group included MT-CO1, sug-
gesting that in mammalian cells, the incorporation of this subunit
occurs at a stage later than the initial one, which instead corre-
sponds to the formation of the COX4I1, COX5A, and HIGD1A
cluster. Finally, the last subunits to be incorporated were exclu-
sively present in fully assembled COX, and their relative amount
was virtually negligible in the mutant cell line.
Identification of a Novel COX Assembly Factor
In order to identifyCOX-specific assembly factors associatedwith
assembly intermediates, we sought proteins associated with
mutantCOXassemblies ingreater abundance thanwithWTcybrid
lines. In a cluster of proteinswithmutant/WT ratios of1.5–2, four
were already known to participate in COX biogenesis, namely,Cell Reports 18, 1727–1738, February 14, 2017 1729
COA3 (CCDC56 orMITRAC12) (Clemente et al., 2013; Mick et al.,
2012), PET100 (Lim et al., 2014; Ola´hova´ et al., 2015; Szklarczyk
et al., 2012), and the human orthologs of the yeast Pet117
(McEwen et al., 1993; Szklarczyk et al., 2012) and Cmc2 (Horn
et al., 2010). In this cluster, we identified a fifth protein, myofibril-
lary-related protein 1 short isoform (MR-1S; also known as PNKD
isoform 2; Uniprot: Q8N490-2), which we investigated further as
a potential, new candidate assembly factor (Figures 1B and 1C).
All the other entries in the cluster were non-mitochondrial pro-
teins according to Mitocarta (http://archive.broadinstitute.org/
pubs/MitoCarta/index.html) and Mitominer (http://mitominer.
mrc-mbu.cam.ac.uk/release-4.0/begin.do), two mitochondrial-
specific proteome databases, and therefore were not consid-
ered relevant for this study. A protein of unknown function,
TMEM214, was further investigated. However, immunofluores-
cence-based subcellular localization showed a non-mitochon-
drial pattern, and knockdown expression of the protein did not
affect COX assembly or function (data not shown).
MR-1S Knockdown Affects COX Assembly and Function
MR-1S is encoded by transcript 3 of the paroxysmal non-kinesi-
genic dyskinesia (PNKD) gene. To further define the role of MR-
1S in COX assembly, we performed lentiviral transduction of
three small hairpin RNAs (shRNAs) specific for PNKD-3 (shMR-
1SRNA1,2,3). From WT cybrids treated with shMR-1SRNA1, we
selected two clones (shMR-1SRNA17 and shMR-1SRNA111),
which showed the virtual absence of MR-1S (Figure 3A). Both
shMR-1SRNA17 and shMR-1SRNA111 cell lines displayed 30%
reduction in COX activity (Figure 3B) compared with cells trans-
duced with the ‘‘empty’’ vector or with an shMR-1SRNA13 clone,
which showed MR-1S levels similar to the control (Figure 3A).
Likewise, shMR-1SRNA17 and shMR-1SRNA111 cell lines
showed reduced oxygen consumption rate (OCR) measured by
Seahorse analysis (Figure 3C). Furthermore, the shRNA cells dis-
played a reduction in the amount of MT-CO1 and COX6A1 incor-
porated into mature COX (by 35% and 60%, respectively)
(Figures 3D–3F). The amount of MT-CO1-immunoreactive sub-
assembly species was not changed in the shRNA clones, except
for a nearly fully assembled species, which was undetectable in
the knockdown cells (Figures 3E and 3F).
MR-1S Interacts with COX Subunits and Assembly
Factors
The migration pattern of MR-1S-containing assembly intermedi-
ates was determined in reciprocal complexome analyses with
SILAC-labeled samples. In the MT-CO3 cybrid cell line, and,
albeit in a lesser amount, in the WT cell line as well, MR-1S
was localized in two main bands in the COX area. One was in sli-
ces 35-37, corresponding to 300-255 kDa, respectively, thus
migrating faster than the COX main band (214 kDa in slice 39),
whereas the second was migrating slower (170 kDa) (Fig-
ure 4A). Importantly, in WT mitochondria, many COX structural
subunits were also detected in the same slices as MR-1S,
although in lower amounts as compared to the main COX band
(Figure 2A). In addition, MR-1S was also detected in the lower-
molecular-weight area at the bottom of the gel (49 and 30 kDa)
in both WT and mutant cells. These data strongly suggest a
role for MR-1S as a chaperone assisting COX assembly.1730 Cell Reports 18, 1727–1738, February 14, 2017Next, we transduced WT and MT-CO3 mutant cybrids with
a C-terminal hemagglutinin (HA)-tagged recombinant MR-1S
cDNA (MR-1SHA) (Figure 4B). As previously reported (Ghezzi
et al., 2009), MR-1SHA was targeted to mitochondria (Figure S2).
By HA immunovisualization, we detected the same two distinct
bands (by WB of 1D-BNGE) or spots (by WB of 2D-BNGE) local-
ized around the band or spot corresponding to fully assembled
COX (Figures 4C and 3D), as previously found by complexome
and SILAC analysis of naive cell lines. This result indicates that
theMR-1SHA protein is incorporated in the same supramolecular
structures as the endogenous one.
To test the specific interaction of MR-1SHA with COX subunits,
we performed co-immunoprecipitation experiments using an
a-HA antibody. No COX subunits were detected in the immuno-
precipitates in control cells (i.e., WT cybrids transduced with
the empty vector), whereas MT-CO1, MT-CO2, COX5A, and
COX5B, but not COX6B, were present in the immunopurifiedma-
terial from MR-1SHA-expressing cells (Figure S3A). In mtDNA
translation experiments, MR-1SHA was able to bind newly syn-
thesized MT-CO2 and, in smaller proportions, MT-CO1 as well
(Figure S3B).
To further explore the MR-1S-specific interactome, we exam-
ined the protein interactions of HA-tagged MR-1S by MS of SI-
LAC-labeled a-HA immunoprecipitates from both WT and MT-
CO3 cybrids. The specific interactors consistently detected by
these analyses included (1) several COX structural subunits
belonging to the early or intermediate assembly groups and (2)
two COX assembly factors, i.e., PET100 (Church et al., 2005;
Lim et al., 2014; Ola´hova´ et al., 2015) and PET117 (McEwen
et al., 1993; Soto et al., 2012; Szklarczyk et al., 2012) (Figures
4E and 4F).
MR-1S-PET100 Complexes Identified by Complexome
Profiling
To gain further insight on the physiological interactions of MR-
1S, we performed complexome profiling of mitochondria iso-
lated from 143B cells and C-124 human skin fibroblasts (Figures
5A and 5B). In both cell types, HIGD1A was detected in all blue
native (BN) gel slices where COX subunits were present (i.e.,
in the monomeric COX, cIII2 + cIV supercomplex and in the
larger COX-containing supercomplexes), qualifying HIGD1A as
a constitutive subunit of the COX complex (Figure 5B). Both
MR-1S and PET100 were predominantly detected in the region
around the COX holocomplex (214 kDa). Again, both their migra-
tion profiles showed two clear peaks at 160 kDa and 270 kDa,
which were distinctly different from that of the COX monomer
(Figure 5B), indicating that they were bound to COX assembly
intermediates.
Themigration profiles also revealed that the putative assembly
factor PET117 was present in a peak overlapping the COX
holocomplex but showing a ‘‘shoulder’’ coinciding with the
higher-molecular-weight peak containing MR-1S and PET100
(Figure 5B). This suggests an interaction between PET117 and
MR-1S plus PET100 during COX biogenesis.
MR-1S Interacts with PET100 and PET117
The absence of human PET100 is associated with severe, iso-
lated COX deficiency and impaired COX assembly, leading to
Figure 3. COX Functional and Assembly Defects after MR-1S Knockdown
(A) SDS-PAGE andWB analysis showingMR-1S steady-state levels in three different clones (clones shMR-1SRNA13, 7, and 11), isolated after lentiviral transduction
of WT cybrids with pLKO.1 containing a shRNA sequence specifically targeting the MR-1S isoform, in comparison with the mock transduced cells (pLKO.1 is an
empty vector [E.V.]). Tubulin (TUB) was used as the loading control.
(B) COX enzyme activity normalized to citrate synthase (CS) activity. Plotted data are mean ± SD (n = 4).
(C) Respiration measured in the knock-down clones, in comparison with the control (E.V.), as oxygen consumption rate (OCR) in basal conditions (BASAL) and
after addition of the uncoupler FCCP (maximum respiration rate, MRR). Histograms represent the mean ± SD values from three independent experiments, each
with five or six replicates.
(D) 1D-BNGE andWB using a-MT-CO1. The densitometric quantification of theMT-CO1 cIV signal, normalized to the CS signal and expressed as the percentage
of the normalized control signals, of three independent experiments is shown below (mean ± SD).
(E) 1D-BNGE + 2D-SDS-PAGE and WB analysis of the distribution of MT-CO1, MT-CO2, and COX6A1 signals in shMR-1S clones RNA17 and RNA111 in
comparison with the E.V. control.
(F) Graphs showing the densitometric profiles MT-CO1 and COX6A1 signals. The tables show the quantification of the area below the curve (subtracting
the background), expressed as the percentage of the control signal normalized by the corresponding cII-SDHA signal (not depicted). Red arrows indicate an
MT-CO1- and MT-CO2-containing sub-complex present in the control (empty vector [E.V.]) cells but absent in knockdown clones RNA17 and RNA111.a fatal early-onset mitochondrial encephalopathy (Lim et al.,
2014; Ola´hova´ et al., 2015). The role of human PET117 in COX
biogenesis is deemed to be similar to that shown in yeast,
although no experimental confirmation has thus far been pro-
vided in mammalian systems (Szklarczyk et al., 2012). In fibro-
blasts carrying a truncating homozygous p.Gly48* mutation in
PET100 (Ola´hova´ et al., 2015), the MR-1S steady-state levels
were markedly reduced (Figure 6A) and the typical MR-1S-con-
taining supramolecular structures were absent (Figures 6B andS5), suggesting that the stability and interaction of MR-1S
with COX assembly intermediates depend on the presence of
PET100.
Next, we transduced WT cybrids, control, and PET100G48*
immortalized fibroblasts transduced with FLAG-tagged versions
of either PET100 or PET117. All cell lines showed very high
expression of recombinant PET117FLAG, whereas the levels
of PET100FLAG were much lower (Figure 6C) but sufficient to
rescue the COX assembly and activity (Figure S4) and (partially)Cell Reports 18, 1727–1738, February 14, 2017 1731
Figure 4. MR-1S Is Found in Two Distinct Supra-molecular Complexes and Binds COX Structural Subunits and Assembly Factors
(A) SILAC-complexomic profiles for MR-1S and MT-CO2 in WT and MT-CO3 mutant cybrids.
(B) SDS-PAGE and WB analyses showing overexpression of HA-tagged MR-1S (MR-1SHA) in the transduced WT and MT-CO3 mutated cybrids.
(C and D) Native first-dimension (1D-BNGE) (C) and denaturing second-dimension (1D-BNGE + 2D-SDS-PAGE) (D) and WB analyses showing migration of MR-
1SHA inside the two distinct complexes with respect to the MT-CO2 and COX5A signals.
(E and F) Scatterplots (E) and tables (F) showing the log2 and log2 H/L ratios obtained after mass spectrometry analysis of a-HA co-immunoprecipitation
fractions of bi-directional SILAC labeling of WT (left graph) or MT-CO3mutant (right) cybrid cells expressing MR-1SHA, combined with material from empty vector
control cells. Only the upper right quadrants of the plots, showing the statistically significant interactions (based on significance B, Perseus analysis platform; Cox
and Mann, 2008; Tyanova et al., 2016), are displayed. pWPXLd-ires-HygroR, empty vector [E.V.].
See also Figure S3.complement the molecular phenotype of PET100G48* fibroblasts
(Figure 6A).
In SILAC experiments using naive WT cybrids and cybrids
transduced with PET117FLAG, MR-1S was co-immunoprecipi-
tated by an a-FLAG monoclonal antibody, together with early
(COX4I1 and COX5A) and intermediate (MT-CO1, MT-CO2,
COX5B, and COX6C) COX structural subunits and COX11,
another COX assembly factor (Figure 6D). More work is neces-
sary to establish whether COX11 and MR-1S co-operate in
COX assembly. Likewise, in PET100G48* immortalized fibro-
blasts transduced with PET100FLAG, the a-FLAG antibody co-
immunoprecipitated MR-1S, together with MT-CO1, MT-CO2,
COX5A, andCOX5B (Figure 6E). However, no co-immunoprecip-1732 Cell Reports 18, 1727–1738, February 14, 2017itation of any of these proteins was obtained in the PET100G48*
fibroblast cell line transducedwithPET117FLAG (Figure 6E). Taken
together, these results clearly demonstrate that PET117 physi-
cally interacts with MR-1S and with some COX subunits and
that this interaction requires the presence of PET100.
DISCUSSION
Revisiting the COX Assembly Pathway
Both immunocapture/SILAC and complexome/SILAC analyses
converge in defining four groups of subunits (early, intermediate,
late, and last) differentially clustering in subassembly intermedi-
ates during COX biogenesis.
Figure 5. MR-1S and PET100 Are Found in
the Same Complexes in Control Cells
(A) Complexome heatmap of 143B cells (left) and
control fibroblasts (right).
(B) Profiles of selected proteins (HIGD1A, PET117,
PET100, and MR-1S). The profile of COX hol-
ocomplex is in black (see main text for details).The first group includes COX4I1 and COX5A subunits, which
were proposed to be the first to join MT-CO1 and determine
the transition from assembly step 1 (S1, corresponding to mono-
meric MT-CO1) to S2 (Figure 7A). Accordingly, these two
subunits were found in several early, low-molecular-weight sub-
complexes. In immunoprecipitation and SILAC experiments,
HIGD1A, which is proposed to mainly interact with MT-CO1
(Hayashi et al., 2015), appeared with the same relative abun-
dance in the MT-CO3 mutant versus WT cells and in low-
molecular-weight subcomplexes, like the subunits COX4I1 and
COX5A. However, in complexome experiments, HIGD1A also
co-migrates with higher-order COX structures (from 300 to
500 kDa) in a non-stoichiometric proportion compared to the
other COX subunits (Figure 2B). HIGD1A is a mammalian ortho-
log of Rcf1, a COX-interacting factor that helps stabilize the
cIII2 + cIV(1-2) supercomplexes in yeast (Chen et al., 2012; Stro-
golova et al., 2012; Vukotic et al., 2012), and when bound toCell RepoCOX, it increases its activity (Hayashi
et al., 2015) (Rydstro¨m Lundin et al.,
2016). Thus, HIGD1A may be a regulatory
component of COX, which is incorpo-
rated in the early stages of the enzyme
assembly.
Unexpectedly, both the immunopre-
cipitation/SILAC and complexome ana-
lyses showed MT-CO1 to be part of the
intermediate assembly group of COX
subunits rather than the early-assembly
group including COX4I1 and COX5A. Pre-
vious studies have shown that the knock-
down of COX4I1 expression results in a
similar decrease in the COX5A steady-
state levels and vice versa. In addition,
the levels of fully assembled COX were
the same as the residual levels of either
subunit (Fornuskova et al., 2010). This is
consistent with the idea that these sub-
units interact and play a seminal role in
the first stages of COX assembly. Impor-
tantly, the total amount of MT-CO1 was
unchanged, but there was an accumula-
tion of MT-CO1-containing assembly in-
termediates. These findings support the
idea that shortage of the COX4I1 +
COX5A early subassembly impairs the
incorporation of MT-CO1, leading to
accumulation of MT-CO1 intermediates,
concordant with the idea of a separate
MT-CO1 module. This later incorporationof MT-CO1 was also previously suggested in S. cerevisiae
(Church et al., 2005), and is in agreement with kinetic experi-
ments of mitochondrial translation after doxycycline treatment
(Moreno-Lastres et al., 2012).
Our complexome profiling confirmed that the intermediate
assembly group includes, in addition to MT-CO1, the subunits
MT-CO2, COX5B, COX6C, COX7C, and COX8A.
In the current model, the incorporation of MT-CO3 occurs just
before or concomitantly with the intermediate group of subunits
(Figure 7A). However, our data indicate that the incorporation of
the nucleus-encoded accessory subunits (COX5B, COX6C,
COX7C, and COX8A) parallels that of MT-CO2 and MT-CO1
and occurs before, rather than after, the incorporation of MT-
CO3 (Figures 1, 2, and 7B).
In fact, our data indicate that the late assembly group in-
cludes subunit MT-CO3, together with COX6A1, COX6B1, and
COX7A2. The ‘‘last’’ group includes two proteins: NDUFA4,rts 18, 1727–1738, February 14, 2017 1733
Figure 6. PET117 Interaction with MR-1S and COX Subunits Is Mediated by PET100
(A) Steady-state levels of proteins visualized by SDS-PAGE, WB, and immunodetection in the PET100G48* patient and in control (WT) immortalized fibroblasts
transducedwith PET100FLAG. The proteinswere detectedwith the indicated antibodies. The signal intensities expressed as percentage of the control (WT_E.V.) of
MT-CO2,MT-CO1, andMR-1S normalized to tubulin are plotted in the top graph (mean ± SD; n = 2). The signal intensities expressed as percentage of the control
(WT_E.V.) of MT-CO2 and MT-CO1 normalized to the MR-1S signal are plotted in the bottom graph (mean ± SD; n = 2). See also Figure S4.
(B) 1D-BNGE, WB, and immunodetection analysis showing the absence of fully assembled COX, detected with a-MT-CO2, and of the MR-1S supramolecular
complexes in the PET100G48* primary fibroblasts. See also Figure S5.
(C) SDS-PAGE, WB, and immunodetection using a-FLAG. Actin and tubulin (TUB) are loading standards. Notice that a long exposure was necessary to visualize
the PET100FLAG band.
(D) Scatterplots and heavy-to-light (H/L) ratio table obtained after mass spectrometry analysis of a-FLAG co-immunoprecipitation fractions of bi-directional
SILAC labeling of cybrid cells expressing recombinant PET117FLAG, combinedwith material from empty vector cybrid cells. Only the top right quadrant of the plot
and the statistically significant interactions are shown (significance B, Perseus analysis platform; Cox and Mann, 2008; Tyanova et al., 2016).
(E) SDS-PAGE, WB analysis, and immunodetection of the co-immunoprecipitation fractions using a-FLAG in PET100G48* immortalized fibroblasts over-
expressing PET100FLAG or PET117FLAG. TOT, total mitoplast lysate before co-immunoprecipitation. FT, flow-through fraction with the unbound proteins. WASH1
andWASH9, fractions obtained after the first and ninth washings of the a-FLAG-M2-agarose resin. ELUTE, eluted fractions of thematerial bound to the resin after
treatment with the specific FLAG peptide.which is peripherally associated with COX (Balsa et al., 2012;
Kadenbach and H€uttemann, 2015; Pitceathly et al., 2013), and
COX7A2L, which is necessary for the formation of cIII2 + cIV (Co-
gliati et al., 2016; Pe´rez-Pe´rez et al., 2016; Williams et al., 2016).
The incorporation of COX6B1 and COX6A1 in the late assembly
group is in agreement with data obtained from the analysis of
COX6B1 mutant human fibroblasts (Massa et al., 2008) and
knockdown expression of COX6A1 in human cells (Fornuskova
et al., 2010). In addition, our results confirm that COX7A2 (the1734 Cell Reports 18, 1727–1738, February 14, 2017non-muscular isoform of COX7A), rather than COX7B (Nijtmans
et al., 1998; Stiburek et al., 2006), belongs to the late assembly
group (Fornuskova et al., 2010) (Figure 7A). We have evidence
that COX7B could in fact be incorporated with the intermediate
assembly group (data not shown).
The current human COX assembly model is based on the
sequential incorporation of individual subunits into a progres-
sively bigger supramolecular structure. However, a modular
assembly model has recently been suggested for the yeast
Figure 7. New Complex IV Assembly Model versus the Reference Assembly Model
(A) Reference assembly model based on Nijtmans et al. (1998); Stiburek et al. (2005), (2006).
(B) New modular assembly model. Each of the modules corresponds to one of the mtDNA-encoded subunits (MT-CO1, MT-CO2, and MT-CO3). The MT-CO1
module is labeled as the MITRAC complex (Mick et al., 2012). Proteins whose genes have been found mutated in mitochondrial disorders are displayed in red.enzyme (McStay et al., 2013a, 2013b, 2013c; Su et al., 2014).
Likewise, in human cultured cells, MT-CO1 was found to
participate in an assembly module termed MITRAC (for mito-
chondrial translation/regulation of assembly intermediates of
COX) (Dennerlein et al., 2015; Mick et al., 2012), together
with COX structural subunits and the assembly factors
COA3 (MITRAC12), COA1 (C7orf44 or MITRAC15), COX14
(C12orf62), CMC1, and SURF1. In yeast, a second module
contains Cox3 together with Cox4 (ortholog of human
COX5B), Cox7 (COX7A), and Cox13 (COX6A). A third module
consists of Cox2 together with other yet-to-be-determined
subunits (Su et al., 2014). These three modules then join
together, release the chaperones, and give rise to mature
COX. The heavy/light ratios obtained in our SILAC analyses
support the existence of assembly modules rather than
sequential incorporation, where MT-CO2 would form a modulewith at least COX6C, COX7C, COX8A, and COX5B, while MT-
CO3 would go together with COX6A1, COX6B1, and COX7A2
(Figure 7B).
MR-1S Role in COX Assembly and Interaction with
PET117 and PET100
We found MR-1S to interact with COX-related proteins. Accord-
ingly, MR-1SHA binds to a subassembly species composed of
the structural subunits defining the ‘‘S3’’ intermediate in the
COX assembly model, except for MT-CO3. Drastic knockdown
of MR-1S expression had functional consequences on COX ac-
tivity and respiratory function, confirming its involvement in COX
biogenesis. A role in the intermediate assembly steps of COX
is also supported by the fact that the advanced intermediates
and fully assembled COX are less abundant in theMR-1S knock-
down cells.Cell Reports 18, 1727–1738, February 14, 2017 1735
Mutations in exon 1 of the PNKD gene, encoding the mito-
chondrial targeting sequence of MR-1S (S for short) and MR-
1L (L for long), have been associated with the autosomal-
dominant neurological disease paroxysmal non-kinesigenic
dyskinesia (PNKD) (Ghezzi et al., 2009). In contrast with the ubiq-
uitous distribution of MR-1S, MR-1L is only expressed in the
brain. Interestingly, low OCR was found by Seahorse analysis
in patient fibroblasts carrying the A9V mutation (Ghezzi et al.,
2015), but the molecular pathogenic mechanisms of PNKD
remain elusive, since the mutation does not affect the mature
forms of both MR-1S and MR-1L. The function of both MR-1L,
which localizes to mitochondria, and MR-1M, which localizes
to the Golgi apparatus and endoplasmic reticulum (ER), remains
unknown but is likely not related to the COX-specific chaperone
role that we have demonstrated for MR-1S.
Our data show that MR-1S co-immunoprecipitates with
PET100, a known COX assembly factor (Church et al., 2005;
Lim et al., 2014; Ola´hova´ et al., 2015), and vice versa. Yeast
Pet100 is necessary for COX assembly and forms a subcomplex
with Cox7 (COX7A), Cox7a (COX6C), and Cox8 (COX7C)
(Church et al., 1996, 2005). Interestingly, two of the human ortho-
log subunits (COX6C andCOX7C) were present in the same frac-
tions as PET100 when MR-1SHA was immunoprecipitated.
Human skin fibroblasts deficient in PET100 show profoundly
reduced COX levels (Lim et al., 2014; Ola´hova´ et al., 2015). In
PET100G48* mutant cells, MT-CO2 is drastically reduced,
whereas MT-CO1 is also low, but to a lesser extent (Ola´hova´
et al., 2015; Figure 6A). In PET100M1? mutant fibroblasts (Lim
et al., 2014), the turnover of MT-CO2 and MT-CO3 was much
higher than in control cells. This is totally consistent with the
idea that PET100 is important for the formation and/or stabiliza-
tion of the intermediate lacking the MT-CO3 module, which
would be generated when the COX4I1 + COX5A and the MT-
CO1 + MT-CO2 modules get together, preceding the incorpora-
tion of MT-CO3 and its partners. This is the same step in which
we propose that MR-1S binds the COX assembly intermediates.
In addition to PET100, MR-1S interacts with PET117, whose
involvement inCOXassembly in humancellswas neverdescribed
before. By using PET100-defective cells (PET100G48*), we were
able to determine that the interactions among MR-1S, PET117,
and COX structural subunits require PET100. In contrast with
PET100, PET117, and many other COX assembly factors, MR-
1S is present only in vertebrates, suggesting for this protein a
peculiar function that is probably specific to the higher complexity
andplasticity ofCOX in theseorganismscompared to that in yeast
or non-vertebrate pluricellular eukaryotes.EXPERIMENTAL PROCEDURES
Cell Culture
Human 143B osteosarcoma cells and primary and immortalized skin fibro-
blasts were grown at 37C and 5%CO2 in high-glucose plus Glutamax and so-
dium pyruvate DMEM (Life Technologies) supplemented with 10% fetal bovine
serum (FBS), penicillin and streptomycin, and 50 mg/mL uridine. For puromycin
and hygromycin, concentrations were 1 mg/mL and 100 mg/mL, respectively.
Cell Line Generation
Primary skin fibroblasts were immortalized by lentiviral transduction of pLOX-
Ttag-iresTK (Addgene #12246, Tronolab).1736 Cell Reports 18, 1727–1738, February 14, 2017C-terminal HA or FLAG tags were added by PCR amplification. PCR frag-
ments were cloned into pWPXLd-ires-PuroR and pWPXLd-ires-HygroR lentivi-
ral expression vectors, modified versions of pWPXLd (Addgene #12258,
Tronolab). Lentiviral particles were generated in HEK293T packaging cells,
and target cells were transduced as described previously (Perales-Clemente
et al., 2008). 24 hr after transduction, cells were selected for puromycin or
hygromycin resistance.
RNAi was performed by lentiviral transduction of shRNA sequences target-
ing specifically the MR-1S isoform (target 1, 50-GTGGTATCCTCCTCTTCA
TCC-30; target 2, 50-GCCAGCCAAAGGCAAATAAAG-30; and target 3, 50-CTA
GGCTATTGACTGTTAAGT-30), cloned into the pLKO.1-TRC vector (Addgene
#10878) according to the manufacturer’s instructions (https://www.addgene.
org/tools/protocols/plko/).
Native and Denaturing Protein Electrophoresis and WB
Samples forBNGEwerepreparedasdescribedpreviously (Nijtmanset al., 2002;
Wittig et al., 2006). Native samples were run through pre-cast NativePAGE 3%–
12%Bis-Tris gels, while NovexNuPAGE 4%–12%Bis-Tris Gels (Life Technolo-
gies) were used for denaturing conditions.
For WB, samples were electroblotted to PVDF membranes and immunode-
tected using commercial specific antibodies. A detailed list can be found in
Supplemental Experimental Procedures.
Immunodetection signal intensities were quantified using ImageJ.
Quantitative SILAC Mass Spectrometry
The two cell lines to be compared by SILAC (Ong et al., 2002) were grown in
‘‘heavy’’ DMEM containing 15N- and 13C-labeled Arg and Lys and in ‘‘light’’
DMEM containing 14N and 12C Arg and Lys (Sigma-Aldrich). Equal portions
of the differentially labeled cell lines were mixed and solubilized; affinity
purifications were performed using anti-HA-agarose (Cell Signaling), anti-
FLAG-agarose (Sigma-Aldrich), or cIV immunocapture kit (Abcam) beads
and analyzed as described previously (Andrews et al., 2013). See Supple-
mental Experimental Procedures for a detailed explanation.
Complexome Profiling
Mitochondrial samples from 143B cells and human skin fibroblasts (cell line
C-124 from the Radboud Center for Mitochondrial Medicine) or from differen-
tially labeled MT-CO3 mutated and WT cybrids (1:1 mixture of the cells grown
in heavy and light SILAC media) were used for ‘‘complexome profiling,’’ which
was performed and analyzed as previously described (Heide et al., 2012), with
somemodifications for SILAC sample analysis. For a detailed explanation, see
Supplemental Experimental Procedures.
Functional Assays
The activities of COX and citrate synthase (CS) were measured in digitonin-
solubilized cell samples (Tiranti et al., 1995) by spectrophotometry as
described previously (Kirby et al., 2007). The respiratory activity wasmeasured
in whole cells in an XF24 extracellular flux analyzer (Seahorse Biosciences) (In-
vernizzi et al., 2012). Statistical analysis was by unpaired Student’s t test using
GraphPad Prism 5.0a software.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2017.01.044.
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